Featured Publications
Global Perspective on the Impact of the COVID‐19 Pandemic on Rheumatology and Health Equity
Hsieh E, Dey D, Grainger R, Li M, Machado P, Ugarte‐Gil M, Yazdany J. Global Perspective on the Impact of the COVID‐19 Pandemic on Rheumatology and Health Equity. Arthritis Care & Research 2023, 76: 22-31. PMID: 37277949, DOI: 10.1002/acr.25169.Peer-Reviewed Original ResearchMeSH KeywordsCOVID-19Health EquityHealth Services AccessibilityHumansPandemicsRheumatic DiseasesRheumatologySARS-CoV-2ConceptsRheumatic diseasesRheumatology practiceHealth service useHealth care utilizationCOVID-19 morbidityHealth care accessCOVID-19 pandemicMental health outcomesUptake of telemedicinePublic health emergencyPublic health communicationAcute phaseVaccine uptakeCare utilizationVaccination practicesRapid guidelinesWorse diseaseCare accessService useHealth outcomesPatient careDiseaseHealth equityHealth emergencyPandemic wanesGlobal Rheumatology Research: Frontiers, Challenges, and Opportunities
Bilsborrow JB, Peláez‐Ballestas I, Pons‐Estel B, Scott C, Tian X, Alarcon GS, Bucala R, Lewandowski LB, Hsieh E. Global Rheumatology Research: Frontiers, Challenges, and Opportunities. Arthritis & Rheumatology 2021, 74: 1-4. PMID: 34535973, PMCID: PMC8712358, DOI: 10.1002/art.41980.Books
2022
Prolonged COVID-19 symptom duration in people with systemic autoimmune rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance Vaccine Survey
DiIorio M, Kennedy K, Liew JW, Putman MS, Sirotich E, Sattui SE, Foster G, Harrison C, Larché MJ, Levine M, Moni TT, Thabane L, Bhana S, Costello W, Grainger R, Machado PM, Robinson PC, Sufka P, Wallace ZS, Yazdany J, Gore-Massy M, Howard RA, Kodhek MA, Lalonde N, Tomasella LA, Wallace J, Akpabio A, Alpízar-Rodríguez D, Beesley RP, Berenbaum F, Bulina I, Chock EY, Conway R, Duarte-García A, Duff E, Gheita TA, Graef ER, Hsieh E, Kibbi L, Liew DF, Lo C, Nudel M, Singh AD, Singh JA, Singh N, Ugarte-Gil MF, Hausmann JS, Simard JF, Sparks JA. Prolonged COVID-19 symptom duration in people with systemic autoimmune rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance Vaccine Survey. RMD Open 2022, 8: e002587. PMID: 36104117, PMCID: PMC9475962, DOI: 10.1136/rmdopen-2022-002587.Peer-Reviewed Original ResearchMeSH KeywordsArthritis, RheumatoidCOVID-19COVID-19 VaccinesFemaleHumansMaleMiddle AgedRheumatologySurveys and QuestionnairesConceptsSystemic autoimmune rheumatic diseasesCOVID-19 symptom durationSymptom durationAutoimmune rheumatic diseasesCOVID-19 onsetVaccines surveyRheumatic diseasesCOVID-19Test-confirmed COVID-19Complete symptom resolutionCOVID-19 severityCOVID-19 symptomsImmunomodulating medicationsComorbidity countSymptom resolutionBaseline characteristicsClinical characteristicsAcute symptomsVaccine dosesNovel viral variantsHigher oddsLower oddsDay 15Viral variantsLogistic regression
2021
Early experience of COVID-19 vaccination in adults with systemic rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance Vaccine Survey
Sattui SE, Liew JW, Kennedy K, Sirotich E, Putman M, Moni TT, Akpabio A, Alpízar-Rodríguez D, Berenbaum F, Bulina I, Conway R, Singh AD, Duff E, Durrant KL, Gheita TA, Hill CL, Howard RA, Hoyer BF, Hsieh E, Kibbi L, Kilian A, Kim AH, Liew DFL, Lo C, Miller B, Mingolla S, Nudel M, Palmerlee CA, Singh JA, Singh N, Ugarte-Gil MF, Wallace J, Young KJ, Bhana S, Costello W, Grainger R, Machado PM, Robinson PC, Sufka P, Wallace ZS, Yazdany J, Harrison C, Larché M, Levine M, Foster G, Thabane L, Rider LG, Hausmann JS, Simard JF, Sparks JA. Early experience of COVID-19 vaccination in adults with systemic rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance Vaccine Survey. RMD Open 2021, 7: e001814. PMID: 34493645, PMCID: PMC8424419, DOI: 10.1136/rmdopen-2021-001814.Peer-Reviewed Original ResearchConceptsDisease-modifying antirheumatic drugsPatient-reported adverse eventsSystemic rheumatic diseasesCOVID-19 vaccinationRheumatic disease flareRheumatic diseasesDisease flareCOVID-19 vaccineAdverse eventsVaccine efficacyMuscle/joint painJanssen/JohnsonTime of vaccinationFever/chillsCommon rheumatic diseasePatient-reported dataOxford/AstraZenecaEarly experienceVaccines surveyAntirheumatic drugsMedication changesJoint painMost patientsPfizer-BioNTechRheumatoid arthritis
2020
Musculoskeletal ultrasound imaging training, use, and knowledge among rheumatologists in China
Wu M, Peng L, Donroe JH, Kohler MJ, Wang L, Zeng X, Li M, Hsieh E. Musculoskeletal ultrasound imaging training, use, and knowledge among rheumatologists in China. Clinical Rheumatology 2020, 40: 321-330. PMID: 32506316, DOI: 10.1007/s10067-020-05175-4.Peer-Reviewed Original Research
2017
New Roadmap for the Journey From Internist to Rheumatologist
Criscione‐Schreiber L, Brown CR, O'Rourke KS, Fuchs HA, Putterman C, Tan IJ, Valeriano‐Marcet J, Hsieh E, Zirkle S, Bolster MB. New Roadmap for the Journey From Internist to Rheumatologist. Arthritis Care & Research 2017, 69: 769-775. PMID: 27863135, DOI: 10.1002/acr.23151.Peer-Reviewed Original ResearchMeSH KeywordsClinical CompetenceCurriculumHumansInternal MedicineRheumatologistsRheumatologySocieties, MedicalConceptsFellowship training programsReporting milestonesInternal medicine reporting milestonesCurricular milestonesFellowship trainingGraduate Medical Education's Next Accreditation SystemCore curriculumTraining programRheumatology practiceEntrustable professional activitiesACGME core competenciesAmerican CollegeUS training programsNext Accreditation SystemSemiannual evaluationPatient careSpecific training goalsRheumatologistsCurriculum updateTraining journeyEducational activitiesRheumatology training programsProfessional activityAccreditation systemMedicine subspecialties
2016
What Is a Rheumatologist and How Do We Make One?
Brown CR, Criscione-Schreiber L, O'Rourke KS, Fuchs HA, Putterman C, Tan IJ, Valeriano-Marcet J, Hsieh E, Zirkle S, Bolster MB. What Is a Rheumatologist and How Do We Make One? Arthritis Care & Research 2016, 68: 1166-1172. PMID: 26663526, DOI: 10.1002/acr.22817.Peer-Reviewed Original Research